Proton pump inhibitors and 180-day mortality in the elderly after Clostridium difficile treatment

BACKGROUND: There is a reported association between proton pump inhibitor (PPI) exposure and increased risk of Clostridium difficile infection (CDI), but less is known about how this class of medications taken during treatment might influence mortality after CDI. Here we examine 180-day mortality ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradley, Evan Stuart, Howe, Emily, Wu, Xun, Haran, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563367/
https://www.ncbi.nlm.nih.gov/pubmed/31210787
http://dx.doi.org/10.1186/s13099-019-0309-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563367/
https://www.ncbi.nlm.nih.gov/pubmed/31210787
http://dx.doi.org/10.1186/s13099-019-0309-6

Ejemplares similares